{"id":"https://openalex.org/W2099690974","doi":"https://doi.org/10.1016/j.yebeh.2015.09.005","title":"An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam","display_name":"An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam","alternate_titles":[],"publication_year":2015,"publication_date":"2015-09-30","ids":{"openalex":"https://openalex.org/W2099690974","doi":"https://doi.org/10.1016/j.yebeh.2015.09.005","mag":"2099690974","pmid":"https://pubmed.ncbi.nlm.nih.gov/26432008"},"language":"en","primary_location":{"id":"doi:10.1016/j.yebeh.2015.09.005","doi":"https://doi.org/10.1016/j.yebeh.2015.09.005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.yebeh.2015.09.005","pdf_url":"http://www.epilepsybehavior.com/article/S152550501500520X/pdf","source":{"id":"https://openalex.org/S109517664","display_name":"Epilepsy & Behavior","issn_l":"1525-5050","issn":["1525-5050","1525-5069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsy &amp; Behavior","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2099690974"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.epilepsybehavior.com/article/S152550501500520X/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103511682","display_name":"Stephen L. Yates","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Stephen L. Yates","raw_affiliation_strings":["UCB Pharma, Raleigh, NC, USA. Electronic address: Stephen.Yates@ucb.com","UCB Pharma Raleigh NC USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Raleigh, NC, USA. Electronic address: Stephen.Yates@ucb.com","institution_ids":[]},{"raw_affiliation_string":"UCB Pharma Raleigh NC USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049222594","display_name":"Toufic A. Fakhoury","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098196","display_name":"KentuckyOne Health","ror":"https://ror.org/00f1vw968","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098196"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Toufic Fakhoury","raw_affiliation_strings":["Kentucky One Health, Lexington, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kentucky One Health, Lexington, KY, USA","institution_ids":["https://openalex.org/I4210098196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023086562","display_name":"Wei Liang","orcid":"https://orcid.org/0000-0002-8120-7905","observed_orcids":["https://orcid.org/0000-0002-8120-7905"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wei Liang","raw_affiliation_strings":["UCB Pharma, Raleigh, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Raleigh, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051188115","display_name":"Klaus Eckhardt","orcid":"https://orcid.org/0000-0002-5030-0971","observed_orcids":["https://orcid.org/0000-0002-5030-0971"]},"institutions":[{"id":"https://openalex.org/I4210166732","display_name":"UCB Pharma (Germany)","ror":"https://ror.org/05pkeac16","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210166732","https://openalex.org/I85722119"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Klaus Eckhardt","raw_affiliation_strings":["UCB Pharma, Monheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Monheim, Germany","institution_ids":["https://openalex.org/I4210166732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079889841","display_name":"Simon Borghs","orcid":"https://orcid.org/0000-0003-1081-7981","observed_orcids":["https://orcid.org/0000-0003-1081-7981"]},"institutions":[{"id":"https://openalex.org/I4210134054","display_name":"UCB Pharma (United Kingdom)","ror":"https://ror.org/03428qp74","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210134054","https://openalex.org/I85722119"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Simon Borghs","raw_affiliation_strings":["UCB Pharma, Slough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Slough, UK","institution_ids":["https://openalex.org/I4210134054"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102328817","display_name":"Joseph D\u2019Souza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127098","display_name":"UCB Pharma (United States)","ror":"https://ror.org/028qka468","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127098","https://openalex.org/I85722119"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph D'Souza","raw_affiliation_strings":["UCB Pharma, Smyrna, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Smyrna, GA, USA","institution_ids":["https://openalex.org/I4210127098"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5103511682"],"corresponding_institution_ids":[],"apc_list":{"value":3060,"currency":"USD","value_usd":3060},"apc_paid":{"value":3060,"currency":"USD","value_usd":3060},"fwci":9.5958,"has_fulltext":true,"cited_by_count":168,"citation_normalized_percentile":{"value":0.98875375,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"52","issue":"Pt A","first_page":"165","last_page":"168"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.7749999761581421},{"id":"https://openalex.org/keywords/levetiracetam","display_name":"levetiracetam","score":0.9959999918937683},{"id":"https://openalex.org/keywords/brivaracetam","display_name":"brivaracetam","score":1.0},{"id":"https://openalex.org/keywords/antiepileptic-drug-switching","display_name":"antiepileptic drug switching","score":0.9120000004768372},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.8999999761581421},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.9300000071525574},{"id":"https://openalex.org/keywords/antiepileptic-drug-side-effects","display_name":"antiepileptic drug adverse effects","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C2777332695","wikidata":"https://www.wikidata.org/wiki/Q417227","display_name":"Levetiracetam","level":3,"score":0.9528849720954895},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.8542028665542603},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4497796595096588},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.33235931396484375},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.31803181767463684}],"mesh":[{"descriptor_ui":"D000077287","descriptor_name":"Levetiracetam","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010889","descriptor_name":"Piracetam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010889","descriptor_name":"Piracetam","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010889","descriptor_name":"Piracetam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013406","descriptor_name":"Suicide, Attempted","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059020","descriptor_name":"Suicidal Ideation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.yebeh.2015.09.005","doi":"https://doi.org/10.1016/j.yebeh.2015.09.005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.yebeh.2015.09.005","pdf_url":"http://www.epilepsybehavior.com/article/S152550501500520X/pdf","source":{"id":"https://openalex.org/S109517664","display_name":"Epilepsy & Behavior","issn_l":"1525-5050","issn":["1525-5050","1525-5069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsy &amp; Behavior","raw_type":"journal-article"},{"id":"pmid:26432008","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26432008","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsy & behavior : E&B","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1016/j.yebeh.2015.09.005","doi":"https://doi.org/10.1016/j.yebeh.2015.09.005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.yebeh.2015.09.005","pdf_url":"http://www.epilepsybehavior.com/article/S152550501500520X/pdf","source":{"id":"https://openalex.org/S109517664","display_name":"Epilepsy & Behavior","issn_l":"1525-5050","issn":["1525-5050","1525-5069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsy &amp; Behavior","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320311407","display_name":"Sunovion","ror":"https://ror.org/030zc7t66"},{"id":"https://openalex.org/F4320337846","display_name":"UCB Pharma","ror":"https://ror.org/01n029866"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2099690974.pdf","grobid_xml":"https://content.openalex.org/works/W2099690974.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1490310274","https://openalex.org/W1916788136","https://openalex.org/W1970167469","https://openalex.org/W1978723089","https://openalex.org/W1981401201","https://openalex.org/W1992028227","https://openalex.org/W1995505488","https://openalex.org/W2051013481","https://openalex.org/W2066622149","https://openalex.org/W2067241131","https://openalex.org/W2068438517","https://openalex.org/W2091074713","https://openalex.org/W2095271866","https://openalex.org/W2125025004","https://openalex.org/W2154588029","https://openalex.org/W2244444568","https://openalex.org/W2327537006","https://openalex.org/W4232616429","https://openalex.org/W4239594659"],"related_works":["https://openalex.org/W2373039027","https://openalex.org/W2057910453","https://openalex.org/W2790413540","https://openalex.org/W4392843974","https://openalex.org/W4414741620","https://openalex.org/W2987197011","https://openalex.org/W3211772010","https://openalex.org/W2996820569","https://openalex.org/W2613020156","https://openalex.org/W7123344450"],"abstract_inverted_index":{"We":[0],"evaluated":[1],"nonpsychotic":[2],"behavioral":[3],"adverse":[4,171],"events":[5,172],"(BAEs)":[6],"in":[7,41,77,80,86,96,129,135,142,153],"patients":[8,71,105,121,168,186,199],"receiving":[9,22],"levetiracetam":[10],"(LEV)":[11],"who":[12],"switched":[13,122],"to":[14,58,123,150,209],"brivaracetam":[15],"(BRV).":[16],"Patients":[17],"\u226516":[18],"years":[19],"of":[20,36,70,89,94,115,139,190],"age,":[21],"2-3":[23],"antiepileptic":[24],"drugs":[25],"(AEDs),":[26],"including":[27],"LEV":[28,37,57,204],"1-3g/day,":[29],"and":[30,63,84,182],"experiencing":[31,200],"BAEs":[32,141,201],"within":[33],"16":[34],"weeks":[35],"treatment":[38,66,117,164],"initiation,":[39],"enrolled":[40],"an":[42,53],"open-label":[43],"Phase":[44],"3b":[45],"study":[46,196],"(NCT01653262)":[47],"comprising":[48],"a":[49,64,133,177],"\u22641-week":[50],"screening":[51],"period,":[52,118,165],"immediate":[54],"switch":[55],"from":[56,148,193,207],"BRV":[59,124,188],"200mg/day":[60],"(without":[61],"titration),":[62],"12-week":[65],"period.":[67],"The":[68],"percentages":[69],"with":[72,203],"investigator-assessed":[73],"clinically":[74,126],"meaningful":[75,127],"reduction":[76,134],"BAEs,":[78],"shift":[79],"maximum":[81,137],"BAE":[82],"intensity,":[83],"change":[85,147],"health-related":[87],"quality":[88],"life":[90],"(HRQoL)":[91],"(Patient-Weighted":[92],"Quality":[93],"Life":[95],"Epilepsy":[97],"Inventory-Form":[98],"31":[99],"[QOLIE-31-P])":[100],"were":[101],"assessed.":[102],"Of":[103],"29":[104],"enrolled,":[106],"26":[107],"(89.7%)":[108],"completed":[109],"the":[110,113,116,136,163],"study.":[111],"At":[112],"end":[114],"27/29":[119,143],"(93.1%)":[120,144],"had":[125],"reductions":[128],"BAEs.":[130],"Physicians":[131],"reported":[132,169,176],"intensity":[138],"primary":[140],"patients.":[145],"Mean":[146],"baseline":[149],"Week":[151],"12":[152],"QOLIE-31-P":[154],"total":[155],"score":[156],"was":[157],"12.1,":[158],"indicating":[159],"improved":[160],"HRQoL.":[161],"During":[162],"23/29":[166],"(79.3%)":[167],"treatment-emergent":[170],"(TEAEs).":[173],"One":[174],"patient":[175],"serious":[178],"TEAE":[179],"(suicidal":[180],"ideation":[181],"suicide":[183],"attempt).":[184],"Two":[185],"discontinued":[187],"because":[189],"TEAEs.":[191],"Findings":[192],"this":[194],"small":[195],"suggest":[197],"that":[198],"associated":[202],"may":[205],"benefit":[206],"switching":[208],"BRV.":[210]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2099690974","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":24},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
